Astec LifeSciences Limited (NSE:ASTEC)
India · Delayed Price · Currency is INR 636.90
-11.55 (-1.78%)
At close: Feb 13, 2026
Astec LifeSciences Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | -1,348 | -469.3 | 255.65 | 898.59 | 650.49 |
Depreciation & Amortization | 433.07 | 358.17 | 328.56 | 336.55 | 251.49 |
Other Amortization | 4.07 | 4.37 | 7.96 | 7.02 | 5.07 |
Loss (Gain) From Sale of Assets | -20.18 | 1.11 | 5.24 | -0.14 | -2.34 |
Stock-Based Compensation | 0.35 | 3.01 | 3.31 | 1.05 | 0.1 |
Provision & Write-off of Bad Debts | 0.48 | 0.58 | 0.2 | 0.04 | - |
Other Operating Activities | 580.48 | 99.33 | 204.71 | 116.84 | 46.77 |
Change in Accounts Receivable | 188.84 | -135.12 | 1,216 | -836.83 | -301.72 |
Change in Inventory | 158.68 | 989.1 | -1,088 | -831.42 | 150.79 |
Change in Accounts Payable | -77.53 | -888.04 | -142.75 | 607.15 | -666.92 |
Change in Other Net Operating Assets | -4.71 | 139 | -44.33 | -62.79 | -215.35 |
Operating Cash Flow | -83.99 | 102.21 | 746.56 | 236.04 | -81.62 |
Operating Cash Flow Growth | - | -86.31% | 216.28% | - | - |
Capital Expenditures | -218.22 | -1,355 | -1,173 | -1,040 | -1,025 |
Sale of Property, Plant & Equipment | 59.68 | 3.6 | 7.77 | 1.24 | 0.05 |
Other Investing Activities | 6.24 | -0.43 | 39.75 | -0.12 | 294.14 |
Investing Cash Flow | -152.3 | -1,352 | -1,125 | -1,039 | -731.1 |
Short-Term Debt Issued | 100 | - | 1,277 | 920.27 | 483.5 |
Long-Term Debt Issued | 1,610 | 1,990 | 586 | - | 400 |
Total Debt Issued | 1,710 | 1,990 | 1,863 | 920.27 | 883.5 |
Short-Term Debt Repaid | -269.55 | -40.12 | -830 | - | - |
Long-Term Debt Repaid | -817.61 | -439.65 | -427 | - | - |
Total Debt Repaid | -1,087 | -479.77 | -1,257 | - | - |
Net Debt Issued (Repaid) | 622.85 | 1,510 | 606.48 | 920.27 | 883.5 |
Issuance of Common Stock | 0.02 | 0.79 | 1.31 | 2.99 | 6.73 |
Common Dividends Paid | - | -29.41 | -29.41 | -29.38 | -29.36 |
Other Financing Activities | -385.54 | -232.03 | -200.68 | -89.1 | -47.51 |
Financing Cash Flow | 237.33 | 1,250 | 377.7 | 804.78 | 813.36 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | -0.34 |
Net Cash Flow | 1.04 | -0.02 | -0.81 | 2.16 | 0.31 |
Free Cash Flow | -302.21 | -1,253 | -426.03 | -803.74 | -1,107 |
Free Cash Flow Margin | -7.93% | -27.32% | -6.78% | -11.87% | -19.81% |
Free Cash Flow Per Share | -15.41 | -63.88 | -21.73 | -41.01 | -56.50 |
Cash Interest Paid | 385.54 | 232.03 | 200.68 | 89.1 | 47.51 |
Cash Income Tax Paid | -49.92 | 19.65 | 48.9 | 291.5 | 230.11 |
Levered Free Cash Flow | -230.84 | -1,337 | -673.05 | -1,486 | -666.83 |
Unlevered Free Cash Flow | -4.12 | -1,182 | -547.06 | -1,432 | -640.14 |
Change in Working Capital | 265.27 | 104.94 | -59.06 | -1,124 | -1,033 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.